Skip to main content

Expert list · Last reviewed April 17, 2026

Top Rheumatologists for Lupus in Massachusetts

Find top rheumatologists for lupus in Massachusetts. Boston-based specialists with deep experience in autoimmune disease and connective tissue disorders.

Loading map…

Massachusetts has a deep bench of top rheumatologists for lupus, concentrated in the Boston teaching hospitals that see the state's hardest autoimmune cases — here is where to start.

Lupus is notoriously hard to pin down. It mimics other diseases, flares without warning, and can target the kidneys, lungs, brain, or skin in different patients. The rheumatologists below practice at Massachusetts General Hospital and Brigham and Women's Hospital, both of which run high-volume lupus clinics and see patients referred from across New England. Their published research covers the complications that make lupus difficult: lung involvement, overlapping autoimmune conditions, bone loss, and outcomes when other illnesses pile on top.

Paul Dellaripa

Paul Dellaripa, MD

Massachusetts General Hospital

View specialist profile

Dr. Dellaripa practices rheumatology at Massachusetts General Hospital with additional ties to Newton-Wellesley and the Dana-Farber/Brigham and Women's Cancer Center. His clinical focus sits at the overlap of rheumatology and pulmonary medicine, which matters for lupus patients because lung complications are common and often underdiagnosed. He sees patients whose autoimmune disease has started to affect how they breathe, and he works closely with lung specialists on treatment plans. A 2017 review in CHEST Journal on lung manifestations in rheumatic diseases 1 is widely used as a reference by both rheumatologists and pulmonologists.

Elena Massarotti

Elena Massarotti, MD

Massachusetts General Hospital

View specialist profile

Dr. Massarotti cares for patients with lupus and other autoimmune conditions at Massachusetts General Hospital, with additional affiliations at North Shore Medical Center and Northeast Hospital. She is often called on for diagnostic puzzles — patients whose symptoms fit lupus but also overlap with rheumatoid arthritis, Sjögren's, or Lyme disease. Her research spans the antibody patterns and genetic markers that separate these conditions 78, which shapes how she orders and interprets lab work in complicated cases.

Dr. Charles is a physician-scientist at Massachusetts General Hospital who also sees patients at Beth Israel Deaconess Plymouth and Newton-Wellesley. Her lab studies how immune cells drive bone loss in inflammatory arthritis, which speaks directly to lupus patients at risk for osteoporosis from both the disease and long courses of steroids. A 2014 paper in Trends in Molecular Medicine on osteoclasts 12 and a 2012 Journal of Clinical Investigation study on inflammatory arthritis and bone precursors 15 anchor her clinical approach to protecting joints and bones over the long haul.

John Stone

John Stone, M.D.

Massachusetts General Hospital

View specialist profile

Dr. Stone practices at Massachusetts General Hospital and is best known for his work on IgG4-related disease and vasculitis — two conditions that can mimic lupus and lead to misdiagnosis. Patients with unusual lupus presentations, kidney or salivary gland involvement, or prior treatment failures often end up in his clinic. He co-authored the 2012 Chapel Hill Consensus classification of vasculitis 16 and a 2012 New England Journal of Medicine review on IgG4-related disease 17 that together set how these conditions are diagnosed internationally.

Marcy Bolster

Marcy Bolster, MD

Director, Rheumatology Fellowship Training Program

Massachusetts General Hospital

View specialist profile

Dr. Bolster directs the rheumatology fellowship training program at Massachusetts General Hospital and cares for adults with lupus, scleroderma, and other connective tissue diseases. Her clinical experience with scleroderma lung disease, including a 2007 Arthritis & Rheumatism study on cyclophosphamide and quality of life 25, translates well to lupus patients with lung or skin involvement. Because she trains the next generation of rheumatologists, her clinic tends to bring a systematic, protocol-driven approach to complex autoimmune care.

Jeffrey Sparks

Jeffrey Sparks, MD

Associate Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School

Brigham and Women's Hospital

View specialist profile

Dr. Sparks is an associate professor of medicine at Brigham and Women's Hospital and Harvard Medical School. He treats lupus, rheumatoid arthritis, and patients navigating infections or other illnesses alongside autoimmune disease. During the pandemic he led a cohort study on how rheumatic disease patients fared with COVID-19 28 and contributed to work on persistent infection in immunocompromised patients 26. For lupus patients on immunosuppressants, that kind of research shapes practical day-to-day advice on vaccines, infections, and medication timing.

What to look for in a rheumatology specialist

  • Board certification in rheumatology
  • Academic affiliation with a teaching hospital that runs a dedicated lupus clinic
  • Experience with your specific organ involvement (kidney, lung, skin, neurological)
  • Wait time for a new-patient visit and whether they're accepting new patients
  • Insurance compatibility and referral requirements
  • Access to coordinated care with nephrology, dermatology, and maternal-fetal medicine if you may become pregnant

Questions to ask before your first appointment

  • How many lupus patients do you treat each year?
  • Do you work as part of a multidisciplinary team if my lupus affects my kidneys or lungs?
  • What is your approach to monitoring disease activity and adjusting medications?
  • How do you handle flares between scheduled visits?
  • What is your experience managing lupus during pregnancy?
  • Can you coordinate with my primary care doctor and any other specialists I see?

The bottom line

The rheumatologists on this list all practice in Boston and pull referrals from across Massachusetts. If your case is straightforward, a local rheumatologist closer to home may serve you well — ask your primary care doctor for a referral. If you have organ involvement, an unclear diagnosis, or have not improved on standard therapy, seeking a second opinion at one of these academic programs is a reasonable next step.

Sources

  1. 1.
    Lung Manifestations in the Rheumatic DiseasesCHEST Journal, 2017. DOI
  2. 2.
    Invasive Pulmonary Aspergillosis Soon After Therapy With Infliximab, a Tumor Necrosis Factor-Alpha–Neutralizing Antibody: A Possible Healthcare-Associated Case?Infection Control and Hospital Epidemiology, 2003. DOI
  3. 3.
    Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial PneumoniaOpen Journal of Rheumatology and Autoimmune Diseases, 2012. DOI
  4. 4.
    Survival and outcomes after lung transplantation for non-scleroderma connective tissue–related interstitial lung diseaseThe Journal of Heart and Lung Transplantation, 2017. DOI
  5. 5.
    The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung DiseaseAdvances in Therapy, 2019. DOI
  6. 6.
    The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritisJournal of Clinical Epidemiology, 2002. DOI
  7. 7.
    Regulation of anti–cyclic citrullinated peptide antibodies in rheumatoid arthritis: Contrasting effects of HLA–DR3 and the shared epitope allelesArthritis & Rheumatism, 2005. DOI
  8. 8.
    The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE statusGenes and Immunity, 2004. DOI
  9. 9.
    Lichen planus–like eruptions: An emerging side effect of tumor necrosis factor-α antagonistsJournal of the American Academy of Dermatology, 2009. DOI
  10. 10.
    Treatment of early lyme diseaseThe American Journal of Medicine, 1992. DOI
  11. 11.
    Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14Current Biology, 1999. DOI
  12. 12.
    Osteoclasts: more than ‘bone eaters’Trends in Molecular Medicine, 2014. DOI
  13. 13.
    A Late Mitotic Regulatory Network Controlling Cyclin Destruction in<i>Saccharomyces cerevisiae</i>Molecular Biology of the Cell, 1998. DOI
  14. 14.
    The Polo-related kinase Cdc5 activates and is destroyed by the mitotic cyclin destruction machinery in S. cerevisiaeCurrent Biology, 1998. DOI
  15. 15.
    Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor functionJournal of Clinical Investigation, 2012. DOI
  16. 16.
    2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012. DOI
  17. 17.
    IgG4-Related DiseaseNew England Journal of Medicine, 2012. DOI
  18. 18.
    Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IArthritis & Rheumatism, 2007. DOI
  19. 19.
    IgG4-related diseaseThe Lancet, 2014. DOI
  20. 20.
    IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five PatientsArthritis & Rheumatology, 2015. DOI
  21. 21.
    Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosisArthritis & Rheumatism, 1997. DOI
  22. 22.
    Ulnar artery involvement in systemic sclerosis (scleroderma).PubMed, 2002.
  23. 23.
    Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis.PubMed, 2005.
  24. 24.
    Imaging of in vitro and in vivo bones and joints with continuous-wave diffuse optical tomographyOptics Express, 2001. DOI
  25. 25.
    Impact of oral cyclophosphamide on health‐related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung studyArthritis & Rheumatism, 2007. DOI
  26. 26.
    Persistence and Evolution of SARS-CoV-2 in an Immunocompromised HostNew England Journal of Medicine, 2020. DOI
  27. 27.
    Rheumatoid ArthritisAnnals of Internal Medicine, 2018. DOI
  28. 28.
    Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot‘Annals of the Rheumatic Diseases, 2020. DOI
  29. 29.
    Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort studyAnnals of the Rheumatic Diseases, 2014. DOI
  30. 30.
    Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort StudyArthritis & Rheumatology, 2019. DOI

Related specialist lists